Left Atrial Appendage Absent
0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
AtriCureAtriClip
AtriCureAtriClip
Clinical Trials (2)
Total enrollment: 6,729 patients across 2 trials
Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial
Start: Jan 2023Est. completion: Apr 20326,573 patients
N/AActive Not Recruiting
VCLIP Post-Market Study, Long-term Follow-up on LAA Exclusion Using AtriClip
Start: Jan 2022Est. completion: Jul 2024156 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.